Abstract
In 1988, Sudoh and co-workers first isolated a novel peptide from porcine brain and designated the peptide “brain natriuretic peptide,” or BNP, based on its similarity to atrial natriuretic peptide (ANP) (1). BNP also was isolated from the cardiac tissue of pigs, rats, and humans (2–5). Owing to its presence in cardiac tissue, the designation “brain natriuretic peptide” is a misnomer. Hence, the designation “B-type natriuretic peptide” is currently used. Subsequent immunological studies identified the cardiac ventricle as the major source of circulating BNP in humans (6). Additional studies indicated that the left ventricle is the major source of circulating BNP and that the release of BNP into the circulation is stimulated by increased ventricular wall tension and volume overload (7–11).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78–81.
Saito Y, Nakao K, Itoh H, et al. Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun 1989; 158: 360–368.
Itoh H, Nakao K, Kamhayashi Y, et al. Occurrence of a novel cardiac natriuretic peptide in rats. Biochem Biophys Res Commun 1989; 161: 732–739.
Kamhayashi Y, Nakao K, Itoh H, et al. Isolation and sequence determination of rat cardiac natriuretic peptide. Biochem Biophys Res Commun 1989; 163: 233–240.
Kamhayashi Y, Nakao K, Mukoyama M, et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett 1990; 259: 341–345.
Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991; 87: 1402–1412.
Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195–203.
McDowell G, Shaw C, Buchanan KD, Nicholls DP. The natriuretic peptide family. Eur J Clin Invest 1995; 25: 291–298.
Davidson NC, Struthers AD. Brain natriuretic peptide. J Hypertens 1994; 12: 329–336.
de Bold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 1996; 31: 7–18.
Yandle TG. Biochemistry of natriuretic peptides. J Intern Med 1994; 235: 561–576.
Tamura N, Ogawa Y, Yasoda A, et al. Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J Mol Cell Cardiol 1996; 28: 1811–1815.
Espiner EA, Richards AM, Yandle TG, Nicholls MG. Natriuretic hormones. Endocrinol Metab Clin North Am 1995; 24: 481–509.
Wilson T, Treisman R. Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3’ AU-rich sequences. Nature 1988; 336: 396–399.
Shaw G, Kamen R. A conserved AU sequence from the 3’ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659–667.
Liang F, Wu J, Garam M, Gardner DG. Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes. J Biol Chem 1997; 272: 28050–28056.
Magga J, Vuolteenaho O, Tokola H, et al. B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Ann Med 1998; 30 (Suppl 1): 39–45.
Weise S, Breyer T, Dragu A, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium. Circulation 2000; 102: 3074–3079.
Molloy SS, Bresnahan PA, Leppla SH, et al. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 1992; 267: 16396–16402.
Dahlen JR, Jean F, Thomas G, et al. Inhibition of soluble recombinant furin by human proteinase inhibitor 8. J Biol Chem 1998; 273: 1851–1854.
Sawada Y, Suda M, Yokoyama H, et al. Stretch-induced hypertrophie growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin. J Biol Chem 1997; 272: 20545–20554.
Lin X, Hanze J, Heese F, et al. Gene expression of natriuretic peptide receptors in myocardial cells. Cire Res 1995; 77: 750–758.
Matsukawa N, Grzesik WJ, Takahashi N, et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 1999; 96: 7403–7408.
Holmes SJ, Espiner EA, Richards AM, et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993; 76: 91–96.
Mair J, Friedl W, Thomas S, Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scan J Clin Lab Invest 1999; 59 (Suppl 230): 132–142.
Malfroy B, Kuang WJ, Seeburg PH, et al. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett 1988; 229: 206–210.
Kenny AJ, Bourne A, Ingram J. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase 24.11. Biochem J 1993; 291: 83–88.
Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin 2001; 19: 557–571.
Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001; 39: 571–588.
Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998; 95: 519–529.
de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014–1021.
Mair J, Friedl W, Thomas S, Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl 1999; 230: 132–142.
Tateyama H, Hino J, Minamino N, et al. Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium. Biochem Biophys Res Commun 1990; 166: 1080–1087.
Shionoria BNP package insert. Shionogi & Co., Osaka, Japan.
Peacock WF. The B-type natriuretic peptide assay: a rapid test for heart failure. Cleve Clin J Med 2002; 69: 243–251.
Triage® BNP Test package insert. Biosite, San Diego, CA.
Heart and Stroke Statistical Update, American Heart Association.
Data on file, Biosite.
Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. J Cardiac Fail 2000; 6: 130–139.
Hammerer-Lercher A, Neubauer E, Muller S, et al. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001; 310: 193–197.
Clerico A, Caprioli R, Del Ry S, Giannessi D. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J Endocrinol Invest 2001; 24: 24–30.
Fischer Y, Filzmaier K, Stiegler H, et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001; 47: 591–594.
Vogeser M, Jacob K. B-type natriuretic peptide (BNP)—validation of an immediate response assay. Clin Lab 2001; 47: 29–33.
Del Ry S, Giannessi D, Clerico A. Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared. Clin Chem Lab Med 2001; 39: 446–450.
Buckley MG, Marcus NJ, Yacoub MH. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice. Clin Sci (Lond) 1999; 97: 689–695.
Buckley MG, Marcus NJ, Yacoub MH, Singer DR. Prolonged stability of brain natriuretic peptide: importance for non-invasive assessment of cardiac function in clinical practice. Clin Sci (Lond) 1998; 95: 235–239.
Murdoch DR, Byrne J, Morton JJ, et al. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 1997; 78: 594–597.
Evans MJ, Livesey JH, Ellis MJ, Yandle TG. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem 2001; 34: 107–112.
Gobinet-Georges A, Valli N, Filliatre H, et al. Stability of brain natriuretic peptide (BNP) in human whole blood and plasma. Clin Chem Lab Med 2000; 38: 519–523.
Shimizu H, Aono K, Masuta K, et al. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta 1999; 285: 169–172.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Dahlen, J.R. (2003). B-Type Natriuretic Peptide. In: Wu, A.H.B. (eds) Cardiac Markers. Pathology and Laboratory Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-385-9_23
Download citation
DOI: https://doi.org/10.1007/978-1-59259-385-9_23
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-319-0
Online ISBN: 978-1-59259-385-9
eBook Packages: Springer Book Archive